4//SEC Filing
Jensen Klavs F. 4
Accession 0001209191-22-032618
CIK 0001604477other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 5:01 PM ET
Size
5.4 KB
Accession
0001209191-22-032618
Insider Transaction Report
Form 4
Jensen Klavs F.
Director
Transactions
- Purchase
Common Stock
2022-05-25$3.52/sh+14,326$50,428→ 353,309 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Includes 1 share of common stock inadvertently omitted from the amount reported in Columns 4 and 5 of the Form 4 filed by the Reporting Person on November 3, 2020 as a result of an error in calculating the aggregation of fractional shares resulting from conversion.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001829257
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 5:01 PM ET
- Size
- 5.4 KB